Compare SCSC & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCSC | ATRC |
|---|---|---|
| Founded | 1992 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.3M | 1.6B |
| IPO Year | 1994 | 2005 |
| Metric | SCSC | ATRC |
|---|---|---|
| Price | $41.04 | $41.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $43.00 | ★ $52.22 |
| AVG Volume (30 Days) | 210.3K | ★ 575.0K |
| Earning Date | 01-29-2026 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.79 | N/A |
| EPS | ★ 3.20 | N/A |
| Revenue | ★ $3,004,880,000.00 | $518,304,999.00 |
| Revenue This Year | $5.96 | $16.90 |
| Revenue Next Year | $5.06 | $12.29 |
| P/E Ratio | $12.84 | ★ N/A |
| Revenue Growth | N/A | ★ 15.80 |
| 52 Week Low | $28.75 | $28.29 |
| 52 Week High | $52.06 | $43.11 |
| Indicator | SCSC | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 62.89 |
| Support Level | $38.90 | $38.92 |
| Resistance Level | $42.24 | $42.60 |
| Average True Range (ATR) | 1.39 | 1.53 |
| MACD | 0.03 | 0.12 |
| Stochastic Oscillator | 47.45 | 80.06 |
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.